ASU researchers: Over-the-counter flu tests can 'revolutionize public health'
iStock photo
Influenza, more commonly known as the flu, causes 50,000-plus of deaths annually, but over-the-counter (OTC) tests for the disease are just beginning to emerge and are difficult to access.
That’s a situation that needs to change, experts say.
In a white paper released July 15 by Arizona State University’s College of Health Solutions, lead researchers Mara Aspinall and Matthew Scotch say OTC tests for the flu would have tremendous potential to improve health outcomes.
The white paper distills insights from a comprehensive roundtable discussion on OTC flu diagnostics that the College of Health Solutions hosted with support from Sanofi Consumer Healthcare. The discussion included 22 experts in infectious diseases, clinical medicine, public health, patient advocacy, retail pharmacy and diagnostics to discuss the future of in-home flu tests.
Scotch, associate dean of research and professor of biomedical informatics in the College of Health Solutions, spoke about the possible benefits of the tests.
"OTC flu tests have the potential to revolutionize public health by making early detection and rapid treatment more accessible for everyone,” Scotch said. “Our roundtable discussion underscored the need for the FDA to prioritize full approval of these tests to maximize their impact on influenza outcomes and public health as soon as possible. We're optimistic and excited about their potential to help patients manage influenza and reduce the burden of this serious disease.”
OTC flu tests can lead to new, faster flu treatment. Home tests could also mean fewer in-person clinic visits and ultimately lower the burden the disease places on society.
As with any new tool, there could be drawbacks to home flu tests. Although it could mean earlier detection and treatment, there could also be challenges with affordability, consumer and provider education as well as integrating the tests with existing health care delivery. However, roundtable participants were optimistic those hurdles could be overcome.
Here are the key takeaway from the white paper. To be effective:
- OTC flu tests must be broadly available.
- OTC flu tests must be priced for accessibility and/or be reimbursed by public and private insurance plans.
- Patients and providers need education on the potential severity of respiratory illness, the use of OTC tests, the potential treatment options and the importance of isolation.
- The best OTC tests will offer simultaneous detection of multiple common respiratory infections.
Read the white paper on the College of Health Solutions website.
More Health and medicine
Human-centered technology embraced at ASU Digital Health Summit
Digital health technology is advancing at lightning speed, but the innovation requires a human touch to ensure that everyone benefits from the advances, according to speakers at the inaugural ASU…
Ancient DNA could help to understand recent tuberculosis outbreak in Kansas
For over a year, Wyandotte and Johnson counties in Kansas City, Kansas, have been fighting an outbreak of tuberculosis (TB) that has claimed two lives and infected nearly 150 residents. The…
ASU researchers propose unifying model of Alzheimer’s disease
In a groundbreaking theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the molecular chaos driving Alzheimer's disease. The condition causes…